Axon Enterprise (NASDAQ:AXON - Get Free Report) is expected to announce its Q1 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect Axon Enterprise to post earnings of $1.34 per share and revenue of $585.67 million for the quarter.
Axon Enterprise Price Performance
Shares of NASDAQ:AXON traded up $7.06 during midday trading on Friday, hitting $628.16. 507,859 shares of the stock were exchanged, compared to its average volume of 758,459. Axon Enterprise has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a 50 day moving average price of $554.17 and a 200-day moving average price of $576.98. The stock has a market cap of $48.90 billion, a P/E ratio of 162.32, a PEG ratio of 5.17 and a beta of 1.13.
Insiders Place Their Bets
In other news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This trade represents a 0.33 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Axon Enterprise
An institutional investor recently bought a new position in Axon Enterprise stock. Brighton Jones LLC purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 808 shares of the biotechnology company's stock, valued at approximately $480,000. Hedge funds and other institutional investors own 79.08% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on AXON shares. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. Barclays restated a "hold" rating on shares of Axon Enterprise in a research report on Monday, March 10th. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target for the company. Finally, JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $626.45.
Check Out Our Latest Analysis on Axon Enterprise
About Axon Enterprise
(
Get Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.